Kimberly Wehger
Chief Tech/Sci/R&D Officer bij ARVINAS, INC.
Profiel
Kimberly Wehger is Vice President-Informatietechnologie bij Arvinas, Inc. In het verleden was mevrouw Wehger Chief Information Officer & Vice President bij New Haven Pharmaceuticals, Inc., Director-Business Engagement bij Alexion Pharmaceuticals, Inc. en Practice Manager-R&D Managed Services bij Veeva Systems, Inc. Ze is afgestudeerd aan de State University of New York in Binghamton en heeft een graad behaald aan de Southern Connecticut State University.
Actieve functies van Kimberly Wehger
| Bedrijven | Functie | Begin |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Kimberly Wehger
| Bedrijven | Functie | Einde |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 01-01-2016 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Opleiding van Kimberly Wehger
| Southern Connecticut State University | Graduate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VEEVA SYSTEMS INC. | Technology Services |
| ARVINAS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
